Liang Shan, Ph.D.
Affiliations: | 2012 | Johns Hopkins University, Baltimore, MD |
Area:
Virology Biology, ImmunologyGoogle:
"Liang Shan"Parents
Sign in to add mentorRobert F. Siliciano | grad student | 2012 | Johns Hopkins | |
(Establishment, reactivation and elimination of the latent reservoir for HIV-1.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
He S, Haikerwal A, Tiwari S, et al. (2025) CD34 serves as an intrinsic innate immune guardrail protecting stem cells from replicating retroviruses. Biorxiv : the Preprint Server For Biology |
Wang Q, Shan L. (2024) Role of the CARD8 inflammasome in HIV pathogenesis. Cell Insight. 3: 100193 |
Eschbach JE, Puray-Chavez M, Mohammed S, et al. (2024) HIV-1 capsid stability and reverse transcription are finely balanced to minimize sensing of reverse transcription products the cGAS-STING pathway. Mbio. e0034824 |
Wang Q, Clark KM, Tiwari R, et al. (2024) The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression. Cell. 187: 1223-1237.e16 |
Pinzone MR, Shan L. (2023) Pharmacological approaches to promote cell death of latent HIV reservoirs. Current Opinion in Hiv and Aids. 19: 56-61 |
Psaros C, Goodman GR, McDonald VW, et al. (2023) Protocol for WeExPAnd: a prospective, mixed-methods pilot demonstration study to increase access to pre-exposure prophylaxis among women vulnerable to HIV infection in the Southern USA. Bmj Open. 13: e075250 |
Clark KM, Wang Q, Shan L. (2023) CARD8 Inflammasome Activation by HIV-1 Protease. Methods in Molecular Biology (Clifton, N.J.). 2641: 67-79 |
Clark KM, Pal P, Kim JG, et al. (2023) The CARD8 inflammasome in HIV infection. Advances in Immunology. 157: 59-100 |
Li Y, Gao H, Clark KM, et al. (2023) IL15 enhances HIV-1 infection by promoting survival and proliferation of CCR5+CD4+ T cells. Jci Insight |
Wang Q, Shan L. (2022) Inflammasomes in Human Immunodeficiency Virus Type 1 Infection. Infectious Diseases & Immunity. 2: 248-252 |